Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells

BACKGROUND: Osteosarcoma (OS) is a malignant tumor of the bone mostly observed in children and adolescents. The current treatment approach includes neoadjuvant and adjuvant chemotherapy; however, drug resistance often hinders therapy in OS patients. Also, the post-relapse survival of OS patients is...

Descripción completa

Detalles Bibliográficos
Autores principales: Saini, Heena, Sharma, Harshita, Mukherjee, Sudeshna, Chowdhury, Shibasish, Chowdhury, Rajdeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807844/
https://www.ncbi.nlm.nih.gov/pubmed/33446200
http://dx.doi.org/10.1186/s12935-020-01720-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807844/
https://www.ncbi.nlm.nih.gov/pubmed/33446200
http://dx.doi.org/10.1186/s12935-020-01720-y

Ejemplares similares